Cardiol Therapeutics Announces Completion of the MAvERIC Phase II Study in Recurrent Pericarditis with Results to be Presented at the American Heart Association Scientific Sessions 2024

. | --- | --- | |----------------------------------------------------|-------| | | | | Cardiol Therapeutics Announces Completion of the | | | MAvERIC Phase II Study in Recurrent Pericarditis | | | with Results to be Presented at the American Heart | | | Association Scientific Sessions 2024 | | Full clinical data will be reported in an oral presentation at the premier global event for advancements in cardiovascular science and medicine on November 18, 2024 September 10, 2024 7:27 AM EDT | Source: Cardiol The ...